Service Corporation International
SCI
$73.72
-0.16%
Service Corporation International (SCI) is a leading provider of funeral and cemetery services and products, operating primarily in the United States and Canada within the consumer cyclical sector's personal products and services industry. The company is the dominant market leader and consolidator in the North American deathcare industry, operating a vast network of funeral homes and cemeteries. The current investor narrative is focused on the stock's defensive characteristics and its recent significant price decline, which may be driven by concerns over its high debt load and potential sensitivity to economic cycles, despite its historically resilient revenue stream and recent announcement of a consistent quarterly cash dividend.…
SCI
Service Corporation International
$73.72
Related headlines
Investment Opinion: Should I buy SCI Today?
Hold. SCI presents a classic 'value trap' scenario—its business is fundamentally sound and cash-generative, but severe balance sheet risks and negative momentum warrant caution until deleveraging progress is demonstrated.
The stock trades at a reasonable forward P/E of 15.3x, a 25% discount to its trailing multiple, reflecting lowered earnings expectations. It generates robust free cash flow ($599.2M TTM) and maintains solid profitability (14.3% net margin). However, these positives are counterbalanced by a high debt-to-equity ratio of 3.14, weak liquidity (current ratio 0.55), and severe technical damage, with the stock down 14.4% over three months and underperforming the S&P 500 by 27.0 percentage points over one year.
The thesis would upgrade to a Buy if the company announces a credible debt reduction plan, demonstrates a return to mid-single-digit revenue growth, and the stock holds firmly above its 52-week low, signaling a stabilization of negative momentum. It would downgrade to a Sell if revenue growth turns negative, free cash flow meaningfully deteriorates, or the stock breaks decisively below the $68.41 support. Relative to its own history and defensive cash flows, the stock appears fairly valued to slightly undervalued, but the valuation does not yet fully compensate for the elevated financial risk.
Sign up to view all
SCI 12-Month Price Forecast
SCI is a financially strained cash cow. Its high-quality, defensive business is overshadowed by a leveraged balance sheet, creating a stalemate that is reflected in its range-bound, bearish technical action. The base case of sideways consolidation is most likely, as the company's strong free cash flow should prevent a collapse, but the debt overhang will limit significant multiple expansion. The stance would upgrade to bullish on clear evidence of deleveraging (e.g., debt-to-equity falling below 2.5) or a sustained technical breakout above $80. It would turn bearish if revenue growth turns negative or free cash flow declines by more than 15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Service Corporation International's 12-month outlook, with a consensus price target around $95.84 and implied upside of +30.0% versus the current price.
Average Target
$95.84
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$59 - $96
Analyst target range
Analyst coverage for SCI appears limited based on the provided data, with only one analyst providing estimates for revenue and EPS, suggesting insufficient breadth to form a robust consensus view. The single analyst's revenue estimate for the next period is approximately $4.77 billion, with a narrow EPS range of $5.03 to $5.11, but no explicit price targets or recommendation distribution are provided in the data. This limited coverage is typical for a mid-cap company in a niche sector and can lead to higher volatility and less efficient price discovery, as the stock may be more influenced by direct investor sentiment and macroeconomic factors than by a broad analyst community.
Bulls vs Bears: SCI Investment Factors
The evidence currently tilts bearish, primarily due to the severe price decline, significant financial leverage, and deteriorating momentum that outweigh the stock's defensive cash flows and attractive valuation. The most critical tension in the SCI investment debate is between its high-quality, cash-generative business model and its precarious financial structure. The resolution of this tension—whether the company can use its strong free cash flow to deleverage its balance sheet without sacrificing growth or dividend stability—will determine the stock's direction. While the valuation appears compelling, the bearish technicals and balance sheet risks suggest the stock is in a 'show me' phase where fundamentals must improve to arrest the decline.
Bullish
- Strong Free Cash Flow Generation: The company generated $599.2 million in trailing-twelve-month free cash flow, providing significant capacity to service its debt, fund operations, and support its recently declared dividend. This robust cash generation underpins the company's financial stability despite its high leverage.
- Defensive Business Model & Stable Margins: SCI's funeral and cemetery services are non-discretionary, providing a resilient revenue stream. This is evidenced by consistent profitability, with a Q4 2025 net margin of 14.3% and an operating margin of 25.0%, indicating solid operational efficiency even in a challenging market.
- Valuation Near 52-Week Low: Trading at $69.81, SCI is just 1.6% above its 52-week low of $68.41, which suggests the stock is deeply oversold. The forward P/E of 15.3x represents a 25% discount to the trailing P/E, indicating the market has priced in significant pessimism, potentially creating a value opportunity.
- Market Leadership & Consolidator Position: As the dominant market leader in the North American deathcare industry, SCI benefits from significant scale and a vast network. This leadership position provides a durable competitive moat and potential for continued strategic acquisitions, supporting long-term cash flow stability.
Bearish
- Extremely High Financial Leverage: SCI's debt-to-equity ratio of 3.14 is alarmingly high, indicating a heavily leveraged balance sheet. This is compounded by a weak current ratio of 0.55, signaling potential liquidity constraints and heightened financial risk, especially in a rising interest rate environment.
- Severe Price & Relative Underperformance: The stock has declined 14.4% over the last three months and 10.57% over the past year, severely underperforming the S&P 500 by 27.0 and 37.6 percentage points, respectively. This persistent negative momentum suggests deep-seated investor concerns that are not being alleviated.
- Modest Revenue Growth & Deceleration: Q4 2025 revenue growth slowed to just 1.69% year-over-year. This deceleration from higher rates in prior quarters raises questions about the company's ability to grow organically, potentially limiting its ability to outgrow its substantial debt burden.
- Vulnerable Technical Support at 52-Week Low: The stock is trading perilously close to its 52-week low of $68.41. A sustained breakdown below this key technical support level could trigger further algorithmic and stop-loss selling, potentially leading to a new leg down in the price.
SCI Technical Analysis
The stock is in a pronounced downtrend, having declined 10.57% over the past year and 14.40% over the last three months, significantly underperforming the S&P 500, which gained 27.04% and 12.6% over the same periods, respectively. With a current price of $69.81, SCI is trading at the very low end of its 52-week range of $68.41 to $88.67, positioning it at just 1.6% above its 52-week low, which suggests the stock is deeply oversold and may represent a potential value opportunity, albeit with significant negative momentum. Recent momentum is decisively negative, with the stock down 12.18% over the past month, a stark contrast to the S&P 500's 4.6% gain, indicating accelerating selling pressure and a severe short-term downtrend that is in sync with the longer-term bearish move. Key technical support is firmly established at the 52-week low of $68.41, while resistance lies near the 52-week high of $88.67; a sustained breakdown below the $68.41 support could signal further downside, whereas a recovery above this level might suggest a stabilization attempt. The stock's beta of 0.888 indicates it is slightly less volatile than the broader market, which is unusual given its recent sharp decline, suggesting the sell-off may be driven by company-specific or sector-specific factors rather than broad market risk.
Beta
0.85
0.85x market volatility
Max Drawdown
-21.6%
Largest decline past year
52-Week Range
$68-$89
Price range past year
Annual Return
-7.2%
Cumulative gain past year
| Period | SCI Return | S&P 500 |
|---|---|---|
| 1m | -5.1% | -0.1% |
| 3m | -7.3% | +11.4% |
| 6m | -6.5% | +8.2% |
| 1y | -7.2% | +22.7% |
| ytd | -4.5% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SCI Fundamental Analysis
Revenue growth has been modest but positive, with Q4 2025 revenue of $1.11 billion representing a 1.69% year-over-year increase, though this growth rate has decelerated from the higher rates seen in prior quarters of 2025. The company's profitability is stable, with a Q4 2025 net income of $159.4 million and a net margin of 14.3%, supported by a gross margin of 28.0% and an operating margin of 25.0%, indicating solid core operational efficiency. However, the balance sheet reveals significant financial leverage, with a high debt-to-equity ratio of 3.14 and a weak current ratio of 0.55, signaling elevated financial risk and potential liquidity constraints, though this is partially offset by robust trailing twelve-month free cash flow of $599.2 million, providing some capacity to service debt and fund operations.
Quarterly Revenue
$1.1B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.28%
Latest Quarter
Free Cash Flow
$599187000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SCI Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The stock trades at a trailing P/E of 20.3x and a forward P/E of 15.3x, with the forward multiple being 25% lower, indicating the market expects earnings growth in the coming year. Compared to sector averages, SCI's trailing P/E of 20.3x is slightly above the typical industry average for consumer services (often in the high teens), suggesting a modest premium that may be attributed to its market-leading position and stable cash flows. Historically, the current trailing P/E of 20.3x is near the middle of its own historical range observed in recent quarters (from a low around 12x in early 2022 to highs above 25x), indicating the stock is not at an extreme valuation level relative to its own history, but the recent price decline has brought the multiple down from higher levels seen earlier in 2025.
PE
20.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 9x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.0x
Enterprise Value Multiple
Investment Risk Disclosure
The primary financial risk is SCI's highly leveraged balance sheet, with a debt-to-equity ratio of 3.14. This substantial debt load, coupled with a weak current ratio of 0.55, creates significant financial risk and potential liquidity constraints. While the company's $599.2M in trailing free cash flow provides a cushion for debt service, any downturn in cash generation or rise in interest expenses could pressure financial flexibility. Revenue concentration in the cyclical 'Consumer Cyclical' sector, despite the defensive nature of funeral services, adds a layer of macro sensitivity, as evidenced by the recent revenue growth deceleration to 1.69% YoY.
Market and competitive risks include valuation compression, as the stock's trailing P/E of 20.3x is slightly above typical industry averages, leaving room for multiple contraction if growth stalls further. The stock's beta of 0.888 suggests it is slightly less volatile than the market, yet its severe underperformance (-37.6% relative strength over one year) indicates company-specific or sector-specific headwinds are driving the sell-off. Competitive risks are muted due to SCI's dominant market position, but the industry faces long-term secular pressures from the rise of low-cost cremation providers and changing consumer preferences, which could pressure pricing power over time.
The worst-case scenario involves a combination of rising interest rates increasing debt servicing costs, a deeper-than-expected economic slowdown reducing discretionary cemetery pre-need sales, and a breakdown of the $68.41 technical support level. This could trigger a vicious cycle of credit rating concerns, forced asset sales, and dividend cuts. Realistic downside could see the stock re-testing its 52-week low, implying a potential loss of approximately -20% from the current price to the $68.41 level, with further downside to the $60 range if sentiment deteriorates severely, aligning with the stock's recent maximum drawdown of -21.6%.
FAQ
The primary risk is financial: an extremely high debt-to-equity ratio of 3.14 and a weak current ratio of 0.55 create vulnerability to rising interest rates or a cash flow downturn. Operational risk includes decelerating revenue growth, which slowed to 1.69% YoY in Q4 2025, potentially limiting its ability to outgrow its debt. Market risk is evident in the stock's severe underperformance, down 10.57% over the past year while the S&P 500 gained 27.04%, driven by sector rotation and leverage concerns. Finally, liquidity and sentiment risk is heightened by thin analyst coverage, which can lead to exaggerated price moves on limited news.
Our 12-month outlook presents three scenarios. The base case (60% probability) sees the stock trading between $72 and $78 as it grapples with high debt but stable cash flows. The bull case (25% probability) projects a rally to $85-$89 on successful deleveraging and a valuation re-rating. The bear case (15% probability) warns of a drop to $60-$68 if leverage fears intensify and technical support fails. The base case is most likely, anchored by the assumption that the company's robust $599M annual free cash flow will prevent a collapse but not be sufficient to drive a major re-rating in the near term.
SCI appears fairly valued to slightly undervalued based on its cash flow generation, but the valuation is justified by its risks. The forward P/E of 15.3x is a 25% discount to its trailing P/E of 20.3x, suggesting the market has priced in slower growth. Compared to sector averages, its trailing P/E is slightly elevated, but this may reflect its market-leading position. The stock is trading just 1.6% above its 52-week low, indicating deep pessimism is already baked in. The valuation implies the market expects stagnant growth and is applying a significant risk premium for the company's leverage.
SCI is a speculative buy for investors with a high risk tolerance and a long time horizon. At its current price near 52-week lows and a forward P/E of 15.3x, it offers a valuation discount for its stable cash flows. However, it carries significant risk due to its high debt-to-equity ratio of 3.14 and weak liquidity (current ratio 0.55). It could be a good buy for contrarian investors betting on a successful deleveraging story, but it is not suitable for risk-averse investors. The limited analyst coverage adds to the uncertainty.
SCI is unsuitable for short-term trading due to its negative momentum, high volatility relative to its beta, and lack of near-term catalysts. It is better suited for long-term, patient investors who can withstand volatility while the company potentially works down its debt over several years. The stock's defensive business model and dividend (recently declared) support a long-term income-and-value thesis. A minimum holding period of 3-5 years is suggested to allow for the execution of a deleveraging strategy and for the market to reappraise the stock once balance sheet health improves.